米非司酮药物流产当日放置依托孕烯植入剂避孕：一项初步研究。
Administration of the etonogestrel contraceptive implant on the day of mifepristone for medical abortion: a pilot study.
机构信息
Department of Obstetrics and Gynecology, Boston University Medical Center.
出版信息
Contraception. 2013 Nov;88(5):671-3. doi: 10.1016/j.contraception.2013.07.008. Epub 2013 Jul 29.
OBJECTIVE
We sought to determine satisfaction and continuation rates of the contraceptive implant when placed on the initial visit for first-trimester medical abortion.
STUDY DESIGN
In this pilot study, we placed the implant within 15 min of mifepristone administration. We assessed satisfaction with implant placement timing, 1-year implant continuation and abortion completion.
RESULTS
We enrolled 20 participants. Sixteen (80%) returned for follow-up, and all had complete abortion. At 1 year, of 16 participants contacted, 14 (87.5%) were satisfied with implant insertion timing, and 14 (87.5%) continued the implant.
CONCLUSIONS
Initiation of the contraceptive implant on the initial visit for medical abortion resulted in high satisfaction and continuation rates.
IMPLICATIONS
This pilot study provides important groundwork for future larger studies to assess initiation of the contraceptive implant on the day of mifepristone for medical abortion.
目的
我们旨在确定在孕早期药物流产初次就诊时放置避孕植入物的满意度和续用率。
研究设计
在这项初步研究中，我们在米非司酮给药后 15 分钟内放置了植入物。我们评估了对植入物放置时机的满意度、1 年内植入物续用和流产完成情况。
结果
我们纳入了 20 名参与者。16 名（80%）人返回进行了随访，所有人都完全流产。在联系的 16 名参与者中，14 名（87.5%）对植入物插入时机感到满意，14 名（87.5%）继续使用植入物。
结论
在药物流产初次就诊时开始使用避孕植入物，满意度和续用率均较高。
意义
这项初步研究为未来更大规模的研究提供了重要基础，以评估在药物流产当天开始使用米非司酮的避孕植入物。
Zotero 插件